International
Via CNN
Eli Lilly's New GLP-1 Pill Aids Significant Weight Loss in Obese Patients, Trial Finds
Eli Lilly's once-daily oral GLP-1 pill helped participants in a Phase 3 trial lower their weight by an average of 12% after 72 weeks.
Advertisement
Eli Lilly's experimental GLP-1 pill has helped people with obesity lose weight by an average of 12% in a 72-week Phase 3 trial, marking a significant milestone for the once-daily oral treatment in treating weight loss.
experimental
glp1
pill
Share this article:
Original source:
CNN
Read Original Article →
